We invite your participation to this exciting event by EPPIC Global, sponsored by Jubilant Biosys Limited on the role of AI/ML in drug discovery.

Machine learning, artificial intelligence, deep learning are buzz words we've all heard, as these technologies promise to transform the landscape of drug discovery. Hear about decoding biology through target-agnostic and engineering mindset approach. Learn about the power of linking different computational technologies needed for Lead Optimization such as multi-parameter optimization platform and experimental integration. Understand insights on pre-competitive consortia and public-private partnerships, different AI/ML approaches taken and expected output.  

But how exactly do they work? What are the tools and various approaches? How AI is addressing the various challenges of the drug discovery process? What are the limitations of each approach? What it can/cannot do? What are the requirements for their successful implementation?

This session will be moderated by Anjali Pandey and will have presentations by Sharath Hegde, Stacie Calad-Thomson, Andrew Radin and Tarangini (Gini) Deshpande.

Title: Role of AI/ML in transforming and accelerating the drug discovery process
Timing: 17 October 2020, 3:00 PM- 4:30 PM, PDT
Register here for $10 - https://bit.ly/30EeD22